Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
about
Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment.Anti-MAdCAM Antibody Increases ß7+ T Cells and CCR9 Gene Expression in the Peripheral Blood of Patients With Crohn's Disease.Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center.
P2860
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@ast
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@en
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@nl
type
label
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@ast
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@en
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@nl
prefLabel
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@ast
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@en
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@nl
P2093
P2860
P356
P1476
Vedolizumab: A novel anti-integrin drug for treatment of inflammatory bowel disease
@en
P2093
Ashish Kumar Kakkar
Ekta Arora
Harish Kumar
Harmanjit Singh
Nipunjot Grewal
P2860
P356
10.4103/0976-9668.175016
P407
P577
2016-01-01T00:00:00Z